Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older
This new plain language summary in Future Virology looks at the latest findings on the role of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.
A plain language summary of the Janssen COVID-19 vaccine effectiveness and safety as a single dose and with a booster
This plain language summary from Future Virology presents the results of two global clinical studies of the Janssen Ad26.COV2.S vaccine against COVID-19.
Janssen single-dose COVID vaccine study results explained in plain language.